Pharmesis International Ltd. (SGX:BFK)
0.4650
0.00 (0.00%)
At close: Aug 11, 2025, 5:00 PM SGT
Pharmesis International Revenue
Pharmesis International had revenue of 43.78M CNY in the half year ending December 31, 2024, with 38.52% growth. This brings the company's revenue in the last twelve months to 70.98M, up 69.75% year-over-year. In the year 2024, Pharmesis International had annual revenue of 67.65M with 48.24% growth.
Revenue (ttm)
70.98M CNY
Revenue Growth
+69.75%
P/S Ratio
1.17
Revenue / Employee
64.76K CNY
Employees
1,096
Market Cap
14.74M SGD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 67.65M | 22.01M | 48.24% |
Dec 31, 2023 | 45.64M | -4.73M | -9.40% |
Dec 31, 2022 | 50.37M | -2.40M | -4.55% |
Dec 31, 2021 | 52.77M | 5.66M | 12.01% |
Dec 31, 2020 | 47.11M | 9.91M | 26.63% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
DBS Group Holdings | 22.10B |
Oversea-Chinese Banking Corporation | 13.72B |
Singapore Telecommunications | 14.13B |
United Overseas Bank | 13.32B |
Singapore Technologies Engineering | 11.67B |
Jardine Matheson Holdings | 45.30B |
Singapore Airlines | 19.54B |
Wilmar International | 88.29B |